About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: March 20, 2020
FDA Guidance on Clinical Trials During COVID-19 Pandemic
Much attention has been paid to the impact of the COVID-19 pandemic on the supply chain for medicines we rely on, but there has been less focus on the impact of medicines yet to come. The advancements in cancer care … Continue reading
Posted in Clinical Trials, FDA Policy
Tagged #COVID-19 #coronavirus #pharma
Comments Off on FDA Guidance on Clinical Trials During COVID-19 Pandemic